Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: 201201017 Principal Investigator: Bartlett, Nancy
Title: A phase 3 open-label randomized study to compare the efficacy and safety of rituximab plus lenalidomide (cc-5013) versus rituximab plus chemotherapy followed by Rituximab in subjects with previously untreated follicular lymphoma
Phase: III Disease Site: Non-Hodgkin's Lymphoma
Participating Site(s):
 
Main Campus
Map and Directions
South County
Map and Directions
St. Peters
Map and Directions
West County
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu

Description:
The purpose of this study is to find out if a drug called lenalidomide when given along with rituximab can help to control the disease and also increase the length of response (complete or partial response) compared to the current standard of care which is rituximab plus chemotherapy treatment.
 
More Information:
ClinicalTrials.gov Link
Internal Protocol Documents (requires Siteman administrative database password)